News

Is Novo Nordisk Immune To President Trump's Drug Price Plans
Discover why Novo Nordisk's stock surged despite CEO changes, driven by GLP-1 success, record sales, and a $2.2B deal to ...
Buy, Sell or Hold: Nuvama downgrades Balkrishna Industries; UBS raises target price on Ashok Leyland
Leading brokerages have updated their outlooks on Ashok Leyland, Balkrishna Industries, and PSP Projects following recent ...